Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Therapeutic Modulation of Transglutaminase 2 by FP-MC in a Rat Model of Alkali-Induced Corneal Injury Achieves Anti-Inflammatory and Anti-Angiogenic Effects

Juan Pablo Salica; Maria Constanza Potilinski; Diego Guerrieri; Eduardo Chuluyan; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5024.

ARVO Annual Meeting Abstract September 2016

Antiangiogenic Effect of a Novel Fusion Protein PFMC inhibiting NFKB pathway on Corneal Alkali Injury Rat Model

Juan Pablo Salica; Alejandro Fichetti; Eduardo Chuluyan; Diego Guerrieri; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3514.

ARVO Annual Meeting Abstract April 2014

Antiinflammatory and antiangiogenic effect of a novel Fusion Protein “SLPI and Cementoin” targeting NF-κB pathway

Juan Pablo Salica; Eduardo Chuluyan; Diego Guerrieri; Gustavo Ortiz; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4725.

ARVO Annual Meeting Abstract March 2012

Intravitreal Administration of FP-MC, Inhibitor of Nuclear Factor KB, Reduced Retinal Immunoreactivity of TNF-a, IL-17, c-PLA2, and GFAP in Type 1 Diabetic Rats

Juan P. Salica; Jorge E. Mancini; Eduardo Chuluyan; Paulo Maffia; Diego Guerrieri; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2794.

ARVO Annual Meeting Abstract April 2011

Effect Of Topical Administration Of Slpi And Fp-mc, Inhibitors Of Nuclear Factor K B, In Rats With Corneal Alkali Burns, 7 Days Post Injury

Juan P. Salica; Eduardo Chuluyan; Juan E. Gallo; Paulo Maffia; Diego Guerrieri; Andrés Rodriguez

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2029.

Advertisement